Skip to main content
Get Alerts

Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to September 2026.

37,059
Total recall recordsAll FDA and USDA recalls in Public Health Trace
9,786
Class I recallsReasonable probability of serious health consequences
24,313
Class II recallsTemporary or medically reversible health consequences
2,876
Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls
Most common hazardLack of Assurance of Sterility 2,072 recalls
Newest recallhttp://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/made-fresh-salads-inc-recalls-ready-eat-deli-style-salads-and-cream-cheese-because-possible-healthPublished September 6, 2026
Most affected stateHawaii 200 recalls mention this state

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters
Recall details
Location
Date range
Sort results
Clear filters
Metric
View
Recalls announced by month (Year to date)

A chart of recalls grouped by month.

Download CSV

Source: FDA and USDA public dataLast updated

Summary (Year to date)

  • 1,527 recalls have been announced year to date.
  • Aug 2026 was 24% lower than the previous complete period (Jul 2026: 240).
  • The highest complete period was Jun 2026 (297).
  • Sep 2026 is incomplete and not included in the figures above.
  • Complete data
  • Incomplete
Recalls by class

A bar chart of the total number of recalls in this dataset by recall class.

Recalls by class
ClassRecalls
Class II24,313
Class I9,786
Class III2,876
Not Yet Classified2
Download CSV
Recalls by class
ClassRecalls
Class II24,313
Class I9,786
Class III2,876
Not Yet Classified2

Showing 581–600 of 18,376 recalls

FDA Recall Ongoing 2026 recordClass II

traMADol Hydrochloride Tablets, USP, 50 mg, 500-count bottles, Rx only, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd., Ahmedabad 382220, India, Distributed by: Amneal Pharmaceuticals LLC, Glasgow, KY 42141, NDC 60219-2348-5.

by Amneal Pharmaceuticals, LLC

Reason
Failed Impurities/Degradation Specifications: N-nitroso-desmethyl-tramadol impurity (NDSRI) was found out of the specification at 24-month stability interval during Long term stability (25¿C/60%RH).
Published
April 8, 2026
Distribution
Nationwide

View recall →

FDA Recall United States Ongoing 2026 recordClass II

JFE FRANCHISING INC

Product
" Dumpling Party Tray (20pcs) Vegetable 13 oz…
Reason
Foreign Object (Glass)
Published
April 8, 2026
Distribution
Multiple states

View recall →

FDA Recall United States Ongoing 2026 recordClass II

JFE FRANCHISING INC

Product
" Dumpling Vegetable 4.5 oz…
Reason
Foreign Object (Glass)
Published
April 8, 2026
Distribution
Multiple states

View recall →

FDA Recall Ongoing 2026 recordClass II

Meclizine Hydrochloride Tablets, USP 12.5 mg, (a) 50 Tablets [5 x 10] (NDC 60687-775-65) (b) 12.5 mg Individual Dose ( NDC 60687-775-11), Rx Only, Distributed by: American Health Packaging, Columbus, Ohio, 43217.

by Amerisource Health Services LLC

Reason
Failed tablet specifications.
Published
April 1, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass II

Octreotide Acetate for Injectable Suspension, for gluteal intramuscular use, 30 mg, Single-dose 8 mL vial in Kit, Rx only, Manufactured in Greece BY: Pharmathen International S.A, Rodopi, 693 00 Greece, Manufactured For: TEVA Pharmaceuticals, Parsippany, NJ 07054, NDC 0480-9262-08.

by Teva Pharmaceuticals USA, Inc

Reason
Lack of Assurance of Sterility: Quality system deficiencies identified during a routine U.S Food and Drug Administration (FDA) inspection at the contract manufacturer.
Published
April 1, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass II

Octreotide Acetate for Injectable Suspension, for gluteal intramuscular use, 20 mg, Single-dose 8 mL vial in Kit, Rx only, Manufactured in Greece BY: Pharmathen International S.A, Rodopi, 693 00 Greece, Manufactured For: TEVA Pharmaceuticals, Parsippany, NJ 07054, NDC 0480-9259-08.

by Teva Pharmaceuticals USA, Inc

Reason
Lack of Assurance of Sterility: Quality system deficiencies identified during a routine U.S Food and Drug Administration (FDA) inspection at the contract manufacturer.
Published
April 1, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass II

Octreotide Acetate for Injectable Suspension, for gluteal intramuscular use, 10 mg, Single-dose 8 mL vial in Kit, Rx only, Manufactured in Greece BY: Pharmathen International S.A, Rodopi, 693 00 Greece, Manufactured For: TEVA Pharmaceuticals, Parsippany, NJ 07054, NDC 0480-9257-08.

by Teva Pharmaceuticals USA, Inc

Reason
Lack of Assurance of Sterility: Quality system deficiencies identified during a routine U.S Food and Drug Administration (FDA) inspection at the contract manufacturer.
Published
April 1, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass II

Levothyroxine Sodium Tablets USP 150 mcg, 1000 Tablets bottle, Rx Only, Manufactured for: Macleods Pharma USA, Inc., Princeton, NJ, Manufactured by: Macleods Pharmaceuticals Ltd., Sarigam, Valsad, Guajarat, INDIA NDC 33342-401-44

by MACLEODS PHARMA USA, INC

Reason
Subpotent Drug
Published
April 1, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass II

CUROSURF (poractant alfa), 240 mg, Intratracheal Suspension, 3L Single-dose-Vial, Rx only, Chiesi USA, Inc, Cary, NC 27518, NDC 10122-510-03.

by Chiesi USA, Inc.

Reason
Lack of Assurance of Sterility
Published
April 1, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass III

Gelatin Capsule Pack for use with the Sodium Iodide I-131 Kit (containing 5 empty capsules and 5 Dibasic Sodium Phosphate Capsules 300 mg, International Isotopes Inc., Idaho Falls, ID 83401. NDC: 69208-003-15; 69208-003-25; 69208-003-35

by Radnostix

Reason
Failed Tablet/Capsule Specifications
Published
April 1, 2026
Distribution
Nationwide

View recall →

FDA Recall United States Ongoing 2026 recordClass II

Western Mixers Produce & Nuts, Inc.

Product
Chilli Spanish Peanuts, Treasured Harvest brand, 25lb clear…
Reason
Foreign object (glass) found inside sealed container of finished product.
Published
April 1, 2026
Distribution
Nationwide

View recall →

FDA Recall United States Ongoing 2026 recordClass II

Western Mixers Produce & Nuts, Inc.

Product
Chilli Spanish Peanuts, First Street brand, 11oz clear plast…
Reason
Foreign object (glass) found inside sealed container of finished product.
Published
April 1, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass I

Webcol Alcohol Prep pad (70% isopropyl alcohol) 2 ply, 200 count boxes, Cardinal Health 200 LLC 3651 Birchwood Drive, Waukegan, IL 60085.

by Cardinal Health 200, LLC

Reason
Non-Sterility: microbial contamination identified as Paenibacillus phoenicis
Published
March 25, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass II

Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution 0.2%/0.5%*, 5 mL, Rx Only, Sterile, Apotex Corp. Manufactured for: Apotex Corp., Weston, FL 33326, NDC 60505-0589-1.

by Apotex Corp.

Reason
Lack of Assurance of Sterility
Published
March 25, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass II

Dexamethasone Sodium Phosphate Injection, USP, 100 mg/ 10 mL, (10 mg/mL), 10x10 mL Multiple Dose Vials, Rx only, Manufactured for: Somerset Therapeutics, LLC., Somerset, NJ 08873, NDC carton: 70069-025-10; NDC vial: 70069-025-01

by SOMERSET THERAPEUTICS LLC

Reason
Failed Impurities/Degradation Specifications - OOS impurities result observed during long term stability testing at product expiry (24 months) were above specs for these impurities: Dexamethasone Sodium Phosphate EP impurity G (Impurity RU 49336) and dexamethasone formate.
Published
March 25, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass II

Children's Ibuprofen Oral Suspension, USP, 100 mg per 5mL, 4 FL OZ (120 mL) bottle, Manufactured for: Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532, Made in India, NDC 51672-5321-8.

by STRIDES PHARMA INC

Reason
Presence of foreign substance: the firm received complaints for a gel-like mass and black particles in the product.
Published
March 25, 2026
Distribution
Nationwide

View recall →

FDA Recall United States Ongoing 2026 recordClass III

Winder Laboratories, LLC

Product
Multivitamin with Fluoride Chewable Tablets Grape Flavor Rx…
Reason
Subpotent. During an FDA inspection it was discovered that the product was subpotent for Vitamin D.
Published
March 25, 2026
Distribution
Product was shipped to the following sta…

View recall →

FDA Recall Ongoing 2026 recordClass II

Icosapent Ethyl Capsules, 1 gram, 120 Capsules per bottle, Rx only, Manufactured by: Softgel Healthcare Pvt. Ltd., India; Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534. NDC: 70710-1592-7

by Zydus Pharmaceuticals (USA) Inc

Reason
Failed Tablet/Capsule specifications: Red dots inside capsule and melted capsule caused by oxidized Icosapent ethyl, the active ingredient.
Published
March 18, 2026
Distribution
Nationwide

View recall →

FDA Recall United States Ongoing 2026 recordClass I

Ambrosia Brands LLC

Product
Rosabella brand MORINGA; DIETARY SUPPLEMENT CAPSULES; 60 cap…
Reason
Product may be contaminated with Salmonella
Published
March 18, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass II

Amnesteem (Isotretinoin) Capsules, USP 40 mg, packaged in 3 x 10-Count Prescription Packs, Rx Only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV, 26505 USA, Made in France, NDC 0378-6614-93.

by MYLAN PHARMACEUTICALS INC

Reason
Failed Dissolution Specifications
Published
March 11, 2026
Distribution
Nationwide

View recall →

Data last updated:

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.